NVNO
enVVeno Medical Corp
$11.12
+0.10 (+0.91%)
At close · Jul 8
Market Cap
$7.34M
Shares
667,669
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$31.24K
-83.3%
FY2019
Net Income
-$19.47M
+10.8%
FY2025
Gross Margin
100%
+99.4pp
FY2018
Operating Margin
-24566.5%
-20356pp
FY2019
Diluted EPS
-$33.06
+25.8%
FY2025
Operating Cash Flow
-$15.57M
+7.5%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | $31.24K | $186.55K | $422.11K | |
| — | — | — | — | $161K | $19K | $3739 | -$49.92K | $298.16K | — | |
| — | — | — | — | — | — | — | — | — | $419.66K | |
| — | — | — | — | — | — | — | — | $186.55K | $2452 | |
| — | — | — | — | — | — | — | — | 100% | 0.58% | |
| $9.54M | $9.98M | $12.25M | $13.58M | $9.91M | $5.73M | $4.25M | $2.21M | $1.24M | $649.74K | |
| $10.47M | $10.92M | $11.58M | $11.66M | $15.02M | $11.17M | $4.88M | $4.91M | $6.48M | $5.46M | |
| — | — | — | — | — | — | — | $77.64K | $111.89K | $123.31K | |
| — | $136K | $189K | $220K | $212K | $149K | $97.55K | $123.66K | $133.42K | $139.21K | |
| -$20.01M | -$20.9M | -$23.83M | -$25.24M | -$24.93M | -$16.89M | -$9.14M | -$7.68M | -$7.85M | -$6.1M | |
| — | — | — | — | — | — | — | -24566.5% | -4210.51% | -1445.89% | |
| — | -$20.76M | -$23.64M | -$25.02M | -$24.72M | -$16.74M | -$9.04M | -$7.55M | -$7.72M | -$5.96M | |
| $1.19M | $1.43M | $2.01M | $1.72M | $263K | $365K | -$360 | -$49.92K | $5.19M | $1.69M | |
| — | — | — | — | $49K | — | — | — | — | — | |
| — | -$19.47M | -$21.82M | — | — | — | — | — | — | — | |
| -$18.82M | -$19.47M | -$21.82M | -$23.52M | -$24.67M | -$16.53M | -$9.14M | -$7.63M | -$13.04M | -$7.79M | |
| — | — | — | — | — | — | — | -24406.74% | -6991.46% | -1845.83% | |
| — | — | — | — | — | -$16.53M | -$9.74M | -$7.63M | -$16.35M | -$8.25M | |
| USD/shares | — | -$33.06 | -$44.53 | -$66.85 | -$77.00 | -$66.50 | — | — | — | — |
| USD/shares | — | -$33.06 | -$44.53 | -$66.85 | -$77.00 | — | — | — | — | — |
| shares | — | 589K | 490K | 351.46K | 320.86K | 248K | 36.9K | 18.01K | 10.7K | 7002.0846 |
| shares | — | 589K | 490K | 351.46K | 320.86K | 247.99K | 36.9K | 18.01K | 10.7K | 7002.0846 |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Medical Devices median 3.66×
EV/EBIT
—
Medical Devices median 21.30×
P/E (TTM)
—
Medical Devices median 26.84×